New research explains how a virus that has already infected up to 80 percent of the American population can repeatedly re-infect individuals despite the presence of a strong and long-lasting immune response. The results of this study primarily illustrate the significant barriers to creating a vaccine that will prevent cytomegalovirus (CMV) infection. This research also explains why CMV might be a useful viral vaccine vector.